- Home
- SGMO vs GLQ Comparison
SGMO vs GLQ Comparison
Compare SGMO & GLQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- GLQ
- Stock Information
- Founded
- SGMO 1995
- GLQ 2005
- Country
- SGMO United States
- GLQ United States
- Employees
- SGMO N/A
- GLQ N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- GLQ Finance/Investors Services
- Sector
- SGMO Health Care
- GLQ Finance
- Exchange
- SGMO Nasdaq
- GLQ Nasdaq
- Market Cap
- SGMO 122.8M
- GLQ 119.5M
- IPO Year
- SGMO 2000
- GLQ N/A
- Fundamental
- Price
- SGMO $0.46
- GLQ $6.76
- Analyst Decision
- SGMO Buy
- GLQ
- Analyst Count
- SGMO 6
- GLQ 0
- Target Price
- SGMO $4.50
- GLQ N/A
- AVG Volume (30 Days)
- SGMO 4.1M
- GLQ 65.5K
- Earning Date
- SGMO 08-05-2025
- GLQ 01-01-0001
- Dividend Yield
- SGMO N/A
- GLQ 11.11%
- EPS Growth
- SGMO N/A
- GLQ N/A
- EPS
- SGMO N/A
- GLQ N/A
- Revenue
- SGMO $63,756,000.00
- GLQ N/A
- Revenue This Year
- SGMO N/A
- GLQ N/A
- Revenue Next Year
- SGMO N/A
- GLQ N/A
- P/E Ratio
- SGMO N/A
- GLQ N/A
- Revenue Growth
- SGMO 239.92
- GLQ N/A
- 52 Week Low
- SGMO $0.30
- GLQ $5.13
- 52 Week High
- SGMO $3.18
- GLQ $6.54
- Technical
- Relative Strength Index (RSI)
- SGMO 38.27
- GLQ 55.71
- Support Level
- SGMO $0.49
- GLQ $6.66
- Resistance Level
- SGMO $0.51
- GLQ $6.92
- Average True Range (ATR)
- SGMO 0.04
- GLQ 0.06
- MACD
- SGMO 0.01
- GLQ -0.03
- Stochastic Oscillator
- SGMO 6.25
- GLQ 55.32
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About GLQ Clough Global Equity Fund Clough Global Equity Fund of Beneficial Interest
Clough Global Equity Fund is a closed-end management investment company. Its investment objective is to provide a high level of total return. The Fund invests in the equity, equity-related securities, and fixed-income securities in both U.S. and non-U.S. markets.